Bacteria and their cell wall components uniformly co-activate interleukin-17-producing thymocytes

Clinical and Experimental Immunology

Volumn 178, Issue 3, 2014, Pages 504-515

  Weber, A ^a   Zimmermann, C ^a   Kieseier, B C ^a   Hartung, H P ^a   Hofstetter, H H ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Cytokines; Inflammation; T cells

Indexed keywords

GAMMA INTERFERON; INFLAMMASOME; INTERLEUKIN 17; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID; PEPTIDOGLYCAN; TEICHOIC ACID; TLR2 PROTEIN, MOUSE; TOLL LIKE RECEPTOR 2;

ANIMAL; BACTERIAL INFECTION; BIOSYNTHESIS; C57BL MOUSE; CD4+ T LYMPHOCYTE; CELL WALL; FEMALE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MICROBIOLOGY; MOUSE; PHYSIOLOGY; THYMOCYTE;

ANIMALS; BACTERIAL INFECTIONS; CD4-POSITIVE T-LYMPHOCYTES; CELL WALL; FEMALE; INFLAMMASOMES; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; PEPTIDOGLYCAN; TEICHOIC ACIDS; THYMOCYTES; TOLL-LIKE RECEPTOR 2;

EID: 84908695377     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12414     Document Type: Article

References (31)

1. Harrington LE, Hatton RD, Mangan PR etal. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005; 6:1123-1132.
2. Korn T, Oukka M, Kuchroo V, Bettelli E. Th17 cells: effector T cells with inflammatory properties. Semin Immunol 2007; 19:362-371.
3. Hofstetter HH, Luhder F, Toyka KV, Gold R. IL-17 production by thymocytes upon CD3 stimulation and costimulation with microbial factors. Cytokine 2006; 34:184-197.
4. Hofmann J, Mair F, Greter M, Schmidt-Supprian M, Becher B. NIK signaling in dendritic cells but not in T cells is required for the development of effector T cells and cell-mediated immune responses. J Exp Med 2011; 208:1917-1929.
5. Marks BR, Nowyhed HN, Choi JY etal. Thymic self-reactivity selects natural interleukin 17-producing T cells that can regulate peripheral inflammation. Nat Immunol 2009; 10:1125-1132.
6. Tanaka S, Yoshimoto T, Naka T etal. Natural occurring IL-17 producing T cells regulate the initial phase of neutrophil mediated airway responses. J Immunol 2009; 183:7523-7530.
7. Kim JS, Smith-Garvin JE, Koretzky GA, Jordan MS. The requirements for natural Th17 cell development are distinct from those of conventional Th17 cells. J Exp Med 2011; 208:2201-2207.
8. Zimmermann C, Weber A, Mausberg AK, Kieseier BC, Hartung HP, Hofstetter HH. T cell activation status determines the cytokine pattern induced by zymosan and bacterial DNA both in thymocytes and splenocytes. Clin Exp Immunol 2013; 172:245-253.
9. Cosmi L, De Palma R, Santarlasci V etal. Human interleukin 17-producing cells originate from a CD161+CD4+ T cell precursor. J Exp Med 2008; 205:1903-1916.
10. Kim JS, Sklarz T, Banks LB etal. Natural and inducible TH17 cells are regulated differently by Akt and mTOR pathways. Nat Immunol 2013; 14:611-618.
11. Billard MJ, Gruver AL, Sempowski GD. Acute endotoxin-induced thymic atrophy is characterized by intrathymic inflammatory and wound healing responses. PLOS ONE 2011; 6:e17940.
12. Wang SD, Huang KJ, Lin YS, Lei HY. Sepsis-induced apoptosis of the thymocytes in mice. J Immunol 1994; 152:5014-5021.
13. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003; 21:335-376.
14. Li H, Nooh MM, Kotb M, Re F. Commercial peptidoglycan preparations are contaminated with superantigen-like activity that stimulates IL-17 production. J Leukoc Biol 2008; 83:409-418.
15. Schwandner R, Dziarski R, Wesche H, Rothe M, Kirschning CJ. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem 1999; 274:17406-17409.
16. Rathinam VA, Vanaja SK, Fitzgerald KA. Regulation of inflammasome signaling. Nat Immunol 2012; 13:333-342.
17. Besnard AG, Togbe D, Couillin I etal. Inflammasome-IL-1-Th17 response in allergic lung inflammation. J Mol Cell Biol 2012; 4:3-10.
18. Henao-Mejia J, Elinav E, Strowig T, Flavell RA. Inflammasomes: far beyond inflammation. Nat Immunol 2012; 13:321-324.
19. Elinav E, Strowig T, Henao-Mejia J, Flavell RA. Regulation of the antimicrobial response by NLR proteins. Immunity 2011; 34:665-679.
20. Weber A, Zimmermann C, Mausberg AK, Kieseier BC, Hartung HP, Hofstetter HH. Induction of pro-inflammatory cytokine production in thymocytes by the immune response modifiers Imiquimod and Gardiquimod. Int Immunopharmacol 2013; 17:427-431.
21. Weber A, Zimmermann C, Meyer Zu Horste G, Kieseier BC, Hartung HP, Hofstetter HH. Bacterial flagellin and diphtheria toxin co-stimulate IL-17-producing thymocytes. Cytokine 2013; 64:221-226.
22. Cua DJ, Tato CM. Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol 2010; 10:479-489.
23. Wang Y, Becker D, Vass T, White J, Marrack P, Kappler JW. A conserved CXXC motif in CD3epsilon is critical for T cell development and TCR signaling. PLOS Biol 2009; 7:e1000253.
24. Nishimoto N, Kishimoto T. Interleukin 6: from bench to bedside. Nat Clin Pract Rheumatol 2006; 2:619-626.
25. Abe R, Oda S, Sadahiro T etal. Gram-negative bacteremia induces greater magnitude of inflammatory response than Gram-positive bacteremia. Crit Care 2010; 14:R27.
26. Alexandraki I, Palacio C. Gram-negative versus Gram-positive bacteremia: what is more alarmin(g)? Crit Care 2010; 14:161.
27. Takeuchi O, Hoshino K, Kawai T etal. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity 1999; 11:443-451.
28. Girardin SE, Travassos LH, Herve M etal. Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2. J Biol Chem 2003; 278:41702-41708.
29. Bettelli E, Carrier Y, Gao W etal. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441:235-238.
30. Smolianov V, Dehmel T, Kieseier BC, Hemmer B, Hartung HP, Hofstetter HH. Ex vivo activation of naturally occurring IL-17-producing T cells does not require IL-6. Cytokine 2012; 58:231-237.
31. Segovia J, Sabbah A, Mgbemena V etal. TLR2/MyD88/NF-kappaB pathway, reactive oxygen species, potassium efflux activates NLRP3/ASC inflammasome during respiratory syncytial virus infection. PLOS ONE 2012; 7:e29695.